18F-FDG PET/CT in patients with suspected recurrent or metastatic well-differentiated thyroid cancer

Amer Shammas, Berna Degirmenci, James M Mountz, Barry M McCook, Barton Branstetter, Badreddine Bencherif, Badreddine B Bencherif, Judith M Joyce, Sally E Carty, Haruko A Kuffner, Norbert Avril
2007 Journal of Nuclear Medicine  
PET using 18F-FDG has been shown to effectively detect various types of cancer by their increased glucose metabolism. The aim of this study was to evaluate the use of coregistered PET and CT (PET/CT) in patients with suspected thyroid cancer recurrence.
pmid:17268018 fatcat:rr24pldkvbg2lblt65olk6hxk4